33
Pharma & HealthcareAvoid
Baroda BNP Paribas Health And Wellness
Baroda BNP Paribas · Direct–Growth · rank #15 of 19 by Smart Score
Data updated
Trailing returns
1 Year
11.4%
+13.5% vs index
3 Years
—
5 Years
—
Since launch
8.3%
Year-by-year performance
2026
+15.5%+19.1% vs index
Why this score
Baroda BNP Paribas Health And Wellness scores 33/100 — #15 of 19 Pharma & Healthcare fund (Avoid). It stands out for volatility — beating 97% of peers on volatility. The main drag is its sharpe ratio (better than only 3% of peers).
Each bar shows the fund's percentile vs Pharma & Healthcare peers — a longer bar beats more of the category.
Sharpe ratio0.15 · 3rd percentile in category
Volatility11.42 · 97th percentile in category
Expense ratio1.56% · 3rd percentile in category
Sortino ratio0.22 · 3rd percentile in category
1Y return11.37% · 21st percentile in category
Fund size507.42 Cr · 39th percentile in category
Top holdings
1.Sun Pharmaceutical Industries Ltd9.01%
2.Divi's Laboratories Ltd8.01%
3.Torrent Pharmaceuticals Ltd7.99%
4.Ipca Laboratories Ltd6.23%
5.Lupin Ltd5.99%
33 disclosed equity positions · portfolio as of Aug 2026 · weights are % of total corpus.